Skip to main content
GRML
NASDAQ Life Sciences

Greenland Mines Receives 6-Month Nasdaq Extension to Avoid Delisting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.419
Mkt Cap
$30.794M
52W Low
$0.114
52W High
$3.91
52W Position info
269% above low
Off High info
89% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

GRML has more than doubled off its 52-week low of $0.114 on light trading volume (0.4× avg).

Summary

Greenland Mines Ltd has been granted an additional six-month extension by Nasdaq until September 14, 2026, to regain compliance with the minimum $1 bid price requirement, preventing immediate delisting.


Key Events · Corporate Governance and Compliance · GRML

  • Nasdaq Extension Granted

    Greenland Mines received an additional six-month extension from The Nasdaq Stock Market LLC to meet the minimum $1.00 bid price requirement.

  • New Compliance Deadline

    The company now has until September 14, 2026, to achieve a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.

  • Delisting Risk Remains

    Failure to regain compliance by the new deadline will result in the delisting of the company's common stock from Nasdaq.

  • Follows Prior Non-Compliance Notice

    This extension follows an initial 180-day compliance period that expired on March 18, 2026, after the company was first notified of non-compliance on September 19, 2025.


Analysis · GRML · Life Sciences

This 8-K filing provides a critical update on Greenland Mines' Nasdaq listing status. While the extension prevents immediate delisting, the company still faces the significant challenge of raising its stock price above $1.00 for 10 consecutive business days by September 14, 2026. Given the current stock price of $0.41875, this represents a substantial hurdle. Failure to comply by the new deadline would result in delisting, severely impacting the company's liquidity and investor confidence, especially for a micro-cap company that recently rebranded and announced a new strategic direction. Investors should monitor the company's progress towards compliance closely.

At the time of this filing, GRML was trading at $0.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.8M. The 52-week trading range was $0.11 to $3.91. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRML - Latest Insights

GRML
Jul 28, 2026, 12:37 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.1867 info
Change: -$0.0033 (-2%) info
Market Cap: $28.589M info
GRML
Jul 27, 2026, 2:11 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $0.179
Real-time Price: $0.1867 info
Change: +$0.0077 (+4%) info
Market Cap: $28.589M info
GRML
Jul 23, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.228
Real-time Price: $0.1867 info
Change: -$0.0413 (-18%) info
Market Cap: $28.589M info
GRML
Jul 20, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.190
Real-time Price: $0.1867 info
Change: -$0.0033 (-2%) info
Market Cap: $28.589M info
GRML
Jul 17, 2026, 11:12 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $0.184
Real-time Price: $0.1867 info
Change: +$0.0027 (+1%) info
Market Cap: $28.589M info